Aspeya
At Aspeya, we strive to make a positive difference to the lives of patients and consumers through science, insight, and innovation.
We’re harnessing deep insight and scientific expertise to reimagine how ingredients can be used, and working towards the development and commercialization of a pipeline of wellness and healthcare products and brands.
We’re applying our expertise to innovate in three areas – consumer health, cannabinoids, and inhaled therapeutics.
Aspeya operates as a separate company under the ownership of Philip Morris International Inc., and benefits from access to the oral technology platform of Fertin Pharma.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}